NEW YORK, April 14, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Marketo, Inc. (NASDAQ: MKTO), Dealertrack Holdings, Inc. (NASDAQ: TRAK), Cypress Semiconductor Corporation (NASDAQ: CY), Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), and Integrated Device Technology, Inc. (NASDAQ: IDTI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1034-100free

--

Marketo, Inc. Analyst Notes

On April 9, 2014, Marketo, Inc. (Marketo) announced the winners of its annual Revvie Awards, which recognizes Marketo customers, partners, and individual marketers who created significant impact on revenue and enriched customer relationships through their innovative use of the Company's customer engagement platform. According to the Company, three of its customers, Acquia, Kaiser Permanente of Colorado, and Curves each won the "Most Dramatic Business Impact" award, while some of the Company's partners and individual marketers have been recognized for utilizing Marketo's software to yield substantial results for their clients and companies. Marketo awarded Datarati, The Pedowitz Group, Christine Nurnberger of Sungard Availability Services, Sarah Shelnut, and Egencia's Acquisition Marketing Manager, Jeff Shearer for their contributions to the Company. Marketo presented the awards at the 2014 Marketing Nation Summit. The full analyst notes on Marketo, Inc. are available to download free of charge at:

http://www.analystsreview.com/1034-MKTO-14Apr2014.pdf

--

Dealertrack Holdings, Inc. Analyst Notes

On April 9, 2014, DealerTrack Holdings, Inc. (Dealertrack) announced that Dealertrack Canada completed the launch of its advanced finance portal for Hyundai Auto Canada Corporation and all of Hyundai automobile dealers. According to the Company, the new Hyundai-branded portal, powered by Dealertrack, will be directly and seamlessly integrated into the OEM's systems to enable credit application submissions and deliver real-time data updates, including latest incentives and aftermarket offerings, new inventory and CPO program data to Hyundai dealers who are financing transactions through the Dealertrack Network. The full analyst notes on DealerTrack Holdings, Inc. are available to download free of charge at:

http://www.analystsreview.com/1034-TRAK-14Apr2014.pdf

--

Cypress Semiconductor Corporation Analyst Notes

On April 2, 2014, Cypress Semiconductor Corporation (Cypress) announced the retirement of Executive Vice President and Chief Financial Officer Brad Buss after eight years of service, who will remain in position through June 1, 2014. According to Cypress, current Vice President of Finance Thad Trent will assume the role of EVP and CFO. The Company stated that Buss will continue to assist in the transition on a part-time basis through September 1, 2014, after which he will become a non-employee advisor to the Board and the CEO through April 30, 2015. Cypress said that Thad Trent has 22 years of experience in the technology industry and has held finance management roles at publicly traded companies Wind River Systems and Wyle Electronics, as well as two technology startups before joining Cypress in 2005, where he served as Vice President in 2010. The full analyst notes on Cypress Semiconductor Corporation are available to download free of charge at:

http://www.analystsreview.com/1034-CY-14Apr2014.pdf

--

Allscripts Healthcare Solutions, Inc. Analyst Notes

On April 9, 2014, Allscripts Healthcare Solutions, Inc. (Allscripts) announced that Lakeland Regional Health Systems (LRHS) expanded its use of Allscripts suite of electronic health record (EHR) solutions and services for hospitals and clinics. The Company stated that Allscripts TouchWorks(TM) is a powerful, multi-specialty ambulatory solution that offers automated clinical decision support at the point of care, a configurable clinical desktop, and nearly 800 peer-reviewed Care Guides. In addition, the Company stated that it is a highly customizable solution with an open architecture and efficient workflows that can help improve the patient experience. According to Allscripts, LHRS expands the use of Allscripts TouchWorks(TM) ambulatory EHR and Allscripts Practice Management(TM) clinical and operational solutions, use Allscripts managed services, and implement Allscripts Payerpath(TM) financial management software to help meet the organization's complex business needs of a growing clinical practice and patient population. The full analyst notes on Allscripts Healthcare Solutions, Inc. are available to download free of charge at:

http://www.analystsreview.com/1034-MDRX-14Apr2014.pdf

--

Integrated Device Technology, Inc. Analyst Notes

On April 3, 2014, Integrated Device Technology, Inc. (IDT) announced that its industry-leading timing solution, the 8T49N28x Universal Frequency Translator (UFT) clocking family, received a 2014 Annual Creativity in Electronics (ACE) Award in the 'Ultimate Products' category presented by UBM Tech's EE Times and EDN, two prestigious industry publications. According to IDT, the 8T49N28x UFT family is the first single-chip programmable solution in the industry capable of generating eight different output frequencies with less than 300 fs RMS phase jitter over the standard 12kHz to 20MHz integration range. The full analyst notes on Integrated Device Technology, Inc. are available to download free of charge at:

http://www.analystsreview.com/1034-IDTI-14Apr2014.pdf

--

About Analysts Review We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES: 


        
        - This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        - Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        - This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        - If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
        - For any urgent concerns or inquiries, please contact us at compliance [at]
          AnalystsReview.com.
        - Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research [at] AnalystsReview.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review